Dr Eoin Flanagan is a Professor of Neurology, Chair of the Division of Multiple Sclerosis and Autoimmune Neurology and Program Director of the Autoimmune Neurology Fellowship at Mayo Clinic (Rochester, MN). He completed medical school at University College Dublin in Ireland and undertook neurology residency, fellowships in neuroimmunology and a Masters in Clinical and Translational Science at Mayo Clinic (Rochester, MN). He works in the Neuroimmunology Clinic and the Neuroimmunology Laboratory at Mayo Clinic. His clinical expertise and research is focused on Myelin Oligodendrocyte Glycoprotein (MOG) antibody-associated disease (MOGAD), aquaporin-4 antibody positive and seronegative neuromyelitis optica spectrum disorders (NMOSD), transverse myelitis and other myelopathies, autoimmune encephalitis, paraneoplastic neurologic disorders and multiple sclerosis. He is Principal Investigator on an NIH RO1 grant studying MOGAD and was a member of the International MOGAD Panel that devised its Diagnostic Criteria published in 2023.